Jianxin Capital

Jianxin Capital is a venture capital firm that focuses on risk investments within the healthcare and biomedical sectors, primarily targeting Series B funding rounds for companies based in China. The firm deploys a team of seasoned professional investors and scientific advisors, integrating deep industry expertise with substantial entrepreneurial and investment experience to identify and cultivate high-potential biotechnological ventures. Their approach emphasizes leveraging comprehensive market insight to drive strategic growth.

Founded in 2010 by Yincheng Zhang, Jianxin Capital was established on the premise that specialized capital and guidance were crucial for nurturing the burgeoning healthcare and life sciences ecosystem in China. The firm originated from a clear vision to bridge the divide between scientific breakthroughs and successful market application, capitalizing on the founder's understanding of the sector's unique demands and opportunities.

Jianxin Capital primarily partners with early to growth-stage healthcare and biotechnology companies that require both financial backing and strategic operational support. The firm’s enduring mission is to evolve into a preeminent and globally recognized investment institution within the biomedical arena, actively contributing to advancements that redefine health. They seek to propel innovation by supporting companies capable of making transformative impacts.